Reaction #71684

ord-dedb795f98b84adc88ad77f70f6601e5

Solvents

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    OtherThe DMF was evaporated under vacuum, 5 ml of DCM
  2. 2
    workup.ADDITIONadded
  3. 3
    Washwashed with saturated NaHCO3 solution (5 ml)
  4. 4
    Otherdried on a phase separation cartridge
  5. 5
    Otherevaporated under vacuo
  6. 6
    workup.DISSOLUTIONThe crude material was dissolved in MeCN/DMSO 1:1
  7. 7
    Otherpurified by MDAP

Procedure

To a solution of (3R)-3-methyl-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine (Description 12) (80 mg, 0.259 mmol) in DMF (4 ml) was added 2-methyl-3-pyridinecarboxylic acid (35.6 mg, 0.259 mmol), HOBT.H2O (39.7 mg, 0.259 mmol), HBTU (98 mg, 0.259 mmol) and DIPEA (0.136 ml, 0.778 mmol) and the reaction mixture was stirred at room temperature for 1 h. The DMF was evaporated under vacuum, 5 ml of DCM added and then washed with saturated NaHCO3 solution (5 ml), dried on a phase separation cartridge and evaporated under vacuo. The crude material was dissolved in MeCN/DMSO 1:1 and purified by MDAP to give the title compound (75 mg).

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08536183B2uspto-grants-2013_09